Eikon Therapeutics Stock

Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.

Sign up today and learn more about Eikon Therapeutics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Eikon Therapeutics Stock

Eikon Therapeutics is a biopharmaceutical company employing revolutionary technology at the interface of biology, engineering, and chemistry to discover novel treatments for life-threatening diseases. Eikon’s discovery platform is built on groundbreaking innovations from its founders (Nobel Prize, 2014), culminating in the creation of microscopes that enable real-time, molecular-resolution measurements of protein movement in living cells.

Funding History

May 2021$148M



Luke Lavi


Xavier Darzacq


Roger Perlmutter

Board Member

Dror Berman

Scientific Advisory Board Member

Larry Lasky

Scientific Advisory Board Member

Eric Schmidt

Scientific Advisory Board Member

Eric Betzig

Scientific Advisory Board Member

Robert Tjian

Scientific Advisory Board Member

Tom Cech

Scientific Advisory Board Member

Juan Jaen

Scientific Advisory Board Member

Fei-Fei Li


EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: